MX2015012610A - Pacritinib deuterizado. - Google Patents
Pacritinib deuterizado.Info
- Publication number
- MX2015012610A MX2015012610A MX2015012610A MX2015012610A MX2015012610A MX 2015012610 A MX2015012610 A MX 2015012610A MX 2015012610 A MX2015012610 A MX 2015012610A MX 2015012610 A MX2015012610 A MX 2015012610A MX 2015012610 A MX2015012610 A MX 2015012610A
- Authority
- MX
- Mexico
- Prior art keywords
- pacritinib
- deuterated
- formula
- compound
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Abstract
La presente invención, en una modalidad, proporciona un compuesto de la Fórmula I; (ver Fórmula) o una sal farmacéuticamente aceptable del mismo, en donde las variables mostradas en la Fórmula I son como se definen en la especificación.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361785727P | 2013-03-14 | 2013-03-14 | |
PCT/US2014/023968 WO2014159511A1 (en) | 2013-03-14 | 2014-03-12 | Deuterated pacritinib |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015012610A true MX2015012610A (es) | 2016-02-17 |
Family
ID=51625183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015012610A MX2015012610A (es) | 2013-03-14 | 2014-03-12 | Pacritinib deuterizado. |
Country Status (7)
Country | Link |
---|---|
US (1) | US20160009732A1 (es) |
EP (1) | EP2970213A4 (es) |
JP (1) | JP2016512530A (es) |
AU (1) | AU2014240478A1 (es) |
CA (1) | CA2904148A1 (es) |
MX (1) | MX2015012610A (es) |
WO (1) | WO2014159511A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105017282B (zh) * | 2015-08-28 | 2017-11-07 | 苏州明锐医药科技有限公司 | 帕克替尼的制备方法 |
US10174018B2 (en) | 2016-12-13 | 2019-01-08 | Princeton Drug Discovery Inc | Protein kinase inhibitors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0014022D0 (en) * | 2000-06-08 | 2000-08-02 | Novartis Ag | Organic compounds |
WO2004078682A2 (en) * | 2003-03-05 | 2004-09-16 | Irm Llc | Cyclic compounds and compositions as protein kinase inhibitors |
WO2007058628A1 (en) * | 2005-11-16 | 2007-05-24 | S*Bio Pte Ltd | Heteroalkyl linked pyrimidine derivatives |
-
2014
- 2014-03-12 US US14/772,972 patent/US20160009732A1/en not_active Abandoned
- 2014-03-12 JP JP2016501394A patent/JP2016512530A/ja active Pending
- 2014-03-12 CA CA2904148A patent/CA2904148A1/en not_active Abandoned
- 2014-03-12 WO PCT/US2014/023968 patent/WO2014159511A1/en active Application Filing
- 2014-03-12 EP EP14775007.9A patent/EP2970213A4/en not_active Withdrawn
- 2014-03-12 MX MX2015012610A patent/MX2015012610A/es unknown
- 2014-03-12 AU AU2014240478A patent/AU2014240478A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2016512530A (ja) | 2016-04-28 |
CA2904148A1 (en) | 2014-10-02 |
AU2014240478A1 (en) | 2015-09-17 |
WO2014159511A1 (en) | 2014-10-02 |
EP2970213A1 (en) | 2016-01-20 |
US20160009732A1 (en) | 2016-01-14 |
EP2970213A4 (en) | 2016-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015002040A (es) | Baricitinib deuterado. | |
IN2015DN00598A (es) | ||
PH12015502031A1 (en) | Tetrahydropyrrolothiazine compounds | |
MX2017006266A (es) | Compuestos de heteroarilo como inhibidores de cinasas asociadas al receptor de interleucina 1(irak) y sus usos. | |
EA201591634A1 (ru) | Дигидропиридопиримидиновые соединения | |
MY163187A (en) | Novel imidazo-oxazine compound or salt thereof | |
MX2015012743A (es) | Compuesto de pirazol-amida y sus usos farmaceuticos. | |
MX2015008829A (es) | Momelotinib deuterado. | |
EA201490761A1 (ru) | R(+)-n-формилпропаргиламиноиндан | |
MY162886A (en) | Novel tetrahydropyridopyrimidine compound or salt thereof | |
PH12018500903A1 (en) | Pyranodipyridine compound | |
IN2014DN07996A (es) | ||
EA201591915A1 (ru) | Соединения феноксиэтил дигидро-1h-изохинолина | |
MX2015016332A (es) | Inhibidores de alk biciclicos fusionados. | |
NZ730816A (en) | Quinoline carboxamides for use in the treatment of multiple myeloma | |
IN2014DN10669A (es) | ||
PH12016501183A1 (en) | Novel compound for treatment of severe hypoglycemia | |
PH12016501184A1 (en) | Novel compound for treatment of severe hypoglycemia | |
PH12016501182A1 (en) | Novel compound for treatment of severe hypoglycemia | |
MX2016006807A (es) | Derivados de imidazol. | |
MX2015012610A (es) | Pacritinib deuterizado. | |
EA201690593A1 (ru) | Новые соединения мочевины | |
EA201690908A1 (ru) | Пиразолопиримидиновые соединения | |
UA87694U (uk) | Сполука 4,5,6,7-тетрагідро-3н-2-n-(пара-метоксифенациламіно)-азепіну гідрохлорид з потенційними фізіологічними властивостями | |
UA87254U (ru) | Соединение 1,1-диэтилкарбокси-2-метокси-2-трифторметилэтилен с потенциальными физиологическими свойствами |